NCT02619188

Brief Summary

This study evaluate the rate of nausea and nutritional status in patients with hyperemesis gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The Investigators aim for developing normal range of prealbumin measurements (reference values) during first trimester of pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 2, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 5, 2016

Status Verified

October 1, 2016

Enrollment Period

1.7 years

First QC Date

September 9, 2015

Last Update Submit

October 4, 2016

Conditions

Keywords

NutritionHyperemesis gravidarumPrealbuminQuestionnaire

Outcome Measures

Primary Outcomes (1)

  • Prealbumin in normal pregnancy

    Serum Prealbumin measured during first trimester of pregnancy

    Within 24h at inclusion

Secondary Outcomes (3)

  • Prealbumin related to nutritional parameters

    Within 24h at inclusion

  • Change in Prealbumin

    Patients will be followed until discharge from hospital, a mean of 5 days, and blood sampling repeated at discharge

  • Prealbumin in Hyperemesis gravidarum

    Within 2h from admission to hospital

Study Arms (2)

Hyperemesis gravidarum

Hyperemesis gravidarum patients admitted to hospital PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis), Intervention at discharge : PUQE-form, Nutritional form and Blood sampling

Other: PUQE-form inclusionOther: Nutritional form inclusionOther: Blood sampling inclusionOther: Intervention at discharge

Control: Healthy pregnant women

Outpatients NOT subjected to severe nausea and emesis (PUQE-score \<13). PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis).

Other: PUQE-form inclusionOther: Nutritional form inclusionOther: Blood sampling inclusion

Interventions

PUQE-form encompassing last 24 hours completion

Also known as: Pregnancy Unique Questionnare of Emesis
Control: Healthy pregnant womenHyperemesis gravidarum

Food-list form encompassing last 24 hours completion

Control: Healthy pregnant womenHyperemesis gravidarum

Measurement of biochemical nutrition marker(s); Prealbumin

Control: Healthy pregnant womenHyperemesis gravidarum

PUQE-form, nutritional form and Blood sampling

Hyperemesis gravidarum

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

* Women admitted to hospital due to Hyperemesis gravidarum * Healthy pregnant women (without hyperemesis gravidarum)

You may qualify if:

  • Pregnant women \< 16 weeks of gestation
  • Admitted to hospital for hyperemesis gravidarum (HG group) with nausea and vomiting in pregnancy with at least two of following criteria; weight loss, dehydration, fluid-/electrolyte disturbances, ketonuria

You may not qualify if:

  • Unable to understand Norwegian
  • PUQE-score \>= 13 (control group)
  • Nausea an vomiting in pregnancy caused by other conditions than Hyperemesis gravidarum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital

Bergen, Hordaland, 5021, Norway

RECRUITING

Related Publications (2)

  • Birkeland E, Stokke G, Tangvik RJ, Torkildsen EA, Boateng J, Wollen AL, Albrechtsen S, Flaatten H, Trovik J. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study. PLoS One. 2015 Apr 1;10(4):e0119962. doi: 10.1371/journal.pone.0119962. eCollection 2015.

    PMID: 25830549BACKGROUND
  • Stokke G, Gjelsvik BL, Flaatten KT, Birkeland E, Flaatten H, Trovik J. Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: a 10-year retrospective cohort study. Acta Obstet Gynecol Scand. 2015 Apr;94(4):359-67. doi: 10.1111/aogs.12578. Epub 2015 Feb 17.

    PMID: 25581215BACKGROUND

MeSH Terms

Conditions

Hyperemesis Gravidarum

Condition Hierarchy (Ancestors)

Morning SicknessPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVomitingSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jone Trovik, MD, PhD

    Senior consultant

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jone Trovik, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2015

First Posted

December 2, 2015

Study Start

September 1, 2015

Primary Completion

May 1, 2017

Study Completion

July 1, 2018

Last Updated

October 5, 2016

Record last verified: 2016-10

Locations